Blog Post

Healthcare and Life Sciences Blog
2 MIN READ

Webinar: How Takeda used generative AI to create a report generation app

MatthewAnderson's avatar
Apr 22, 2024

In the healthcare industry, report generation is a crucial and time-consuming task that requires sourcing and populating information from various sources. Takeda, a global biopharmaceutical company, worked with their Microsoft code-with team to create a minimum viable product (MVP) application that could accelerate this process using generative AI.

 

In this webinar, we discussed the experience with Takeda and Microsoft including the challenges, learnings, and reference open-source code on GitHub that was part of the engagement.

 

How Takeda used generative AI in multiple applications | App Chronicles Webinar 2024-04-30 (youtube.com)

Find the slide deck at the bottom of this post.

 

Agenda

  • Overview of the use case and the business problem
  • Demonstration of the MVP app and its features
  • Technical details of how the app was built and where to find the source code
  • Lessons learned

 

Intelligent App Chronicles for Healthcare

The Intelligent App Chronicles for Healthcare is a webinar series designed to provide health and life sciences companies with a comprehensive guide to building intelligent healthcare applications.

 

The series will cover a wide range of topics including Azure Container Services, Azure AI Services, Azure Integration Services, and innovative solutions that can accelerate your Intelligent app journey. By attending these webinars, you will learn how to leverage the power of intelligent systems to build scalable and secure healthcare solutions that can transform the way you deliver care.

 

Our hosts will be: Shelly (Finch) AveryMatthew AndersonRob McKenna & Adam Workman

 

Don’t miss this opportunity to learn from the experts and take your healthcare applications to the next level. Register now for the Intelligent App Chronicles for Healthcare webinar series, here.

Updated May 02, 2024
Version 4.0
No CommentsBe the first to comment